TXMD
TherapeuticsMD, Inc.
Customer concentration
— top 3 customers 100% of revenue
3 customers — 100% of revenue (the three months ended March 31, 2026)
“For the three months ended March 31, 2026, 100% of license revenue related to Mayne Pharma, Theramex and Knight.”
Company with tickers: TXMD
CIK
25743
CUSIP
88338N206
Shares Outstanding
11,574,362
Website
https://www.therapeuticsmd.com
13F Activity (30d)
27 filings
26 filers
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-05-04 | 5,437 | 70,857 | 76,294 | 46.8% |
| 2026-04-27 | 5,487 | 45,067 | 50,554 | 68.6% |
| 2026-04-20 | 9,130 | 48,708 | 57,838 | 62.1% |
| 2026-04-13 | 7,638 | 111,424 | 119,062 | 78.5% |
| 2026-04-06 | 8,216 | 38,387 | 46,603 | 52.1% |
| 2026-03-30 | 10,827 | 39,671 | 50,498 | 50.9% |
| 2026-03-23 | 3,664 | 37,517 | 41,181 | 55.2% |
| 2026-03-16 | 17,453 | 68,051 | 85,504 | 65.7% |
| 2026-03-09 | 10,067 | 57,870 | 67,937 | 65.7% |
| 2026-03-02 | 6,967 | 67,952 | 74,919 | 54.7% |
| 2026-02-23 | 10,049 | 47,461 | 57,510 | 64.4% |
| 2026-02-16 | 3,076 | 60,627 | 63,703 | 58.0% |
| 2026-02-09 | 15,690 | 124,030 | 139,720 | 61.9% |
| 2026-02-02 | 30,656 | 131,640 | 162,296 | 59.4% |
| 2026-01-26 | 27,692 | 429,229 | 456,921 | 61.2% |
| 2026-01-19 | 37,750 | 299,039 | 336,789 | 59.5% |
| 2026-01-12 | 249,475 | 338,206 | 587,681 | 52.7% |
| 2026-01-05 | 24,264 | 529,664 | 553,928 | 58.1% |
| 2025-12-29 | 5,973 | 147,308 | 153,281 | 57.9% |
| 2025-12-22 | 10,143 | 115,933 | 126,076 | 66.5% |
| 2025-12-15 | 13,571 | 103,729 | 117,300 | 53.3% |
Showing 1–21 of 21 weeks